156 related articles for article (PubMed ID: 16191339)
1. [Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy].
Wu ZY; Song GX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):769-71. PubMed ID: 16191339
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and management of Graves' orbitopathy.
Lee HB; Rodgers IR; Woog JJ
Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
[TBL] [Abstract][Full Text] [Related]
3. Thyroid ophthalmopathy.
Levy J; Sobel R; Marcus M; Lifshitz T
Minerva Endocrinol; 2005 Dec; 30(4):247-65. PubMed ID: 16319812
[TBL] [Abstract][Full Text] [Related]
4. Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.
Daumerie Ch; Duprez T; Boschi A
Eur J Intern Med; 2008 Nov; 19(7):531-6. PubMed ID: 19013383
[TBL] [Abstract][Full Text] [Related]
5. [Effects of rh-leptin on the proliferation and migration of orbital preadipocytes of thyroid associated ophthalmopathy].
Tang J; Luo QL; He WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):933-5. PubMed ID: 19253829
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and treatment of thyroid-associated ophthalmopathy.
Gould DJ; Roth FS; Soparkar CN
Aesthetic Plast Surg; 2012 Jun; 36(3):638-48. PubMed ID: 22083413
[TBL] [Abstract][Full Text] [Related]
7. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
8. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of reason and treatment methods for active, refractory and recurrence thyroid associated ophthalmopathy].
Luo QL
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):408-412. PubMed ID: 28606261
[TBL] [Abstract][Full Text] [Related]
10. [Choice the appropriate therapy according to the clinical features of the thyroid associated ophthalmopathy].
Xiao LH
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1060-2. PubMed ID: 17415960
[TBL] [Abstract][Full Text] [Related]
11. Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials.
Banga JP; Nielsen CH; Gilbert JA; El Fassi D; Hegedus L
Thyroid; 2008 Sep; 18(9):973-81. PubMed ID: 18752425
[TBL] [Abstract][Full Text] [Related]
12. Development and application of animal models to study thyroid-associated ophthalmopathy.
Shen F; Liu J; Fang L; Fang Y; Zhou H
Exp Eye Res; 2023 May; 230():109436. PubMed ID: 36914000
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
14. [The pathological changes of the orbital tissue in thyroid associated ophthalmopathy].
Hei Y; Kang L; Li YY; Xiao LH
Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):423-6. PubMed ID: 18953897
[TBL] [Abstract][Full Text] [Related]
15. Eye muscle force development in thyroid-associated ophthalmopathy in different stages of disease.
Tian S; Bolzani R; Benassi M; Lennerstrand G
Acta Ophthalmol Scand; 2007 Jun; 85(4):431-7. PubMed ID: 17559468
[TBL] [Abstract][Full Text] [Related]
16. Update on thyroid eye disease.
Stemberger K; Kahaly GJ; Pitz S
Compr Ophthalmol Update; 2006; 7(6):287-98. PubMed ID: 17244445
[TBL] [Abstract][Full Text] [Related]
17. Leptin receptor is a key gene involved in the immunopathogenesis of thyroid-associated ophthalmopathy.
Chen Z; Chen Z; Wang J; Zhang M; Wang X; Cuomu D; Shi B; Wang Y
J Cell Mol Med; 2021 Jun; 25(12):5799-5810. PubMed ID: 33988300
[TBL] [Abstract][Full Text] [Related]
18. An update on thyroid-associated ophthalmopathy in children and adolescents.
Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
[TBL] [Abstract][Full Text] [Related]
19. [The stepwise establishment of standardized treatment for the thyroid eye disease].
Qian J
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):404-407. PubMed ID: 28606260
[TBL] [Abstract][Full Text] [Related]
20. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
